Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca, Morelos 62271, México.
Department of Marine Biotechnology, Faculty of Naval Medicine, Second Military Medical University, Shanghai, 200433, China.
Biochim Biophys Acta Gen Subj. 2017 Apr;1861(4):936-946. doi: 10.1016/j.bbagen.2017.01.032. Epub 2017 Jan 31.
Scorpion venoms contain toxins that modulate ionic channels, among which are the calcins, a small group of short, basic peptides with an Inhibitor Cystine Knot (ICK) motif that target calcium release channels/ryanodine receptors (RyRs) with high affinity and selectivity. Here we describe the heterologous expression of Intrepicalcin, identified by transcriptomic analysis of venomous glands from Vaejovis intrepidus.
Recombinant Intrepicalcin was obtained in Escherichia coli BL21-DE3 (periplasm) by fusing the Intrepicalcin gene to sequences coding for signal-peptide, thioredoxin, His-tag and enterokinase cleavage site.
[H]Ryanodine binding, used as a functional index of RyR activity, revealed that recombinant Intrepicalcin activates skeletal RyR (RyR1) dose-dependently with K=17.4±4.0nM. Intrepicalcin significantly augments the bell-shaped [Ca]-[H]ryanodine binding curve at all [Ca] ranges, as is characteristic of the calcins. In single channel recordings, Intrepicalcin induces the appearance of a subconductance state in RyR1 with a fractional value ∼55% of the full conductance state, very close to that of Vejocalcin. Furthermore, Intrepicalcin stimulates Ca release at an initial dose=45.3±2.5nM, and depletes ~50% of Ca load from skeletal sarcoplasmic reticulum vesicles.
We conclude that active recombinant Intrepicalcin was successfully obtained without the need of manual oxidation, enabling it to target RyR1s with high affinity.
This is the first calcin heterologously expressed in the periplasma of Escherichia coli BL21-DE3, shown to be pharmacologically effective, thus paving the way for the generation of Intrepicalcin variants that are required for structure-function relationship studies of calcins and RyRs.
蝎毒液含有能调节离子通道的毒素,其中包括钙调蛋白,这是一小群短而碱性的肽,具有抑制半胱氨酸结(ICK)基序,能以高亲和力和选择性靶向钙释放通道/ryanodine 受体(RyRs)。在这里,我们描述了通过对 Vaejovis intrepidus 毒腺的转录组分析鉴定的 Intrepicalcin 的异源表达。
通过将 Intrepicalcin 基因与编码信号肽、硫氧还蛋白、His 标签和肠激酶切割位点的序列融合,在大肠杆菌 BL21-DE3(周质)中获得重组 Intrepicalcin。
[H]ryanodine 结合用作 RyR 活性的功能指标,结果表明重组 Intrepicalcin 以 K=17.4±4.0nM 的浓度依赖方式激活骨骼肌 RyR(RyR1)。Intrepicalcin 显著增加了所有 [Ca]范围内的 [Ca]-[H]ryanodine 结合曲线的钟形曲线,这是钙调蛋白的特征。在单通道记录中,Intrepicalcin 在 RyR1 中诱导出现亚电导状态,其分数值约为全电导状态的 55%,非常接近 Vejocalcin。此外,Intrepicalcin 在初始剂量=45.3±2.5nM 时刺激 Ca 释放,并从骨骼肌肌浆网囊泡中耗竭约 50%的 Ca 负荷。
我们得出结论,无需手动氧化即可成功获得活性重组 Intrepicalcin,使其能够以高亲和力靶向 RyR1s。
这是第一个在大肠杆菌 BL21-DE3 的周质中异源表达的钙调蛋白,被证明具有药理作用,为生成 Intrepicalcin 变体铺平了道路,这些变体对于钙调蛋白和 RyRs 的结构-功能关系研究是必需的。